Novartis

Novartis Recent News

Barron's Best Income Ideas For 2017
|
Barron's Picks And Pans: Trump Stocks, Hillary Stocks, Safe European Yields And More
|
Regeneron Is 'One Of The Stronger Growers In Biotech'
|
Novartis Announces The Establishment Of FortiHFy, But What Is It?
|
Bayer's Latest Stage 2 Trial Could Be A Boon For Shares
|
Repeat Performance In Aveo Pharmaceuticals After Spike In Price
|
5 New Medical Technologies For Diabetics
|
Novartis Joins Google To Develop Contacts For Diabetics
|
Markets Sell-Off After Malaysian Airline Crash In Ukraine
|
ASCO Meeting Day 1: Preserving Fertility And Reducing Side Effects
|
Surges In Biotech Short Interest (INCY, PCYC, REGN)
|
Market Wrap For April 24: Apple's Smashing Earnings Overshadowed By Ukraine Concerns
|
Market Wrap For March 27: Markets Lower Following Mixed Economic Data
|
Market Wrap For March 25: Markets Snap Two-Day Losing Steak On Confidence Data
|
Market Wrap For March 18: Markets Positive Despite Crimea Concerns
|
The Top Five Dow Stocks In February
|
Market Wrap For February 26: Markets Slightly Higher On Housing Data
|
GlaxoSmithKline, Kinder Morgan And Others Insiders Have Been Buying
|

Connect With Us

instagramlinkedinyoutube

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2025 Benzinga | All Rights Reserved